Astex Pharmaceuticals to Announce 2013 First Quarter Financial Results on April 29th
April 22, 2013 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., April 22, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals Provides SGI-110 Update
April 10, 2013 06:00 ET
|
Astex Pharmaceuticals, Inc.
Oral Presentation at AACR Supports Potential of SGI-110 In The Treatment Of Platinum-Resistant Ovarian Cancer
Clinical Update on SGI-110-01 Study
DUBLIN, Calif., April 10, 2013 (GLOBE NEWSWIRE)...
Astex Pharmaceuticals Pipeline Data Presentations at AACR
April 03, 2013 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., April 3, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals to Present at ROTH Conference
March 12, 2013 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., March 12, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals Reports 2012 Fourth Quarter and Year-End Financial Results
February 25, 2013 16:00 ET
|
Astex Pharmaceuticals, Inc.
Reports Annual Net Income of $8.2 Million
Dacogen Royalty Revenue Increases 17.5% from Prior Year
Ends Year with $138 Million in Cash & Marketable Securities
DUBLIN, Calif., Feb. 25, 2013...
Astex Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference
February 20, 2013 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Feb. 20, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals to Announce 2012 Fourth Quarter and Year-End Financial Results on February 25th
February 19, 2013 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Feb. 19, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals to Present at BIO CEO & Investor Conference
February 05, 2013 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Feb. 5, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Cancer Research UK and Cancer Research Technology Initiate AT13148 Clinical Trial to Treat Several Cancer Types
January 16, 2013 20:32 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Jan. 16, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals to Present at Biotech Showcase 2013
January 03, 2013 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Jan. 3, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...